pharma · Familial adenomatous polyposis (FAP) · Familial Adenomatous Polyposis · BDRX
Biodexa Pharmaceuticals
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals patent portfolio — 2 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- cardiff, GB
- Founded
- 2000
- Employees
- 25
- Programs
- 4
- Drugs
- 5
- Patents
- 2
Biodexa Pharmaceuticals patents
2 pharmaceutical patents indexed for Biodexa Pharmaceuticals. 1 expire within 24 months.
Biodexa Pharmaceuticals has 2 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Biodexa Pharmaceuticals have?
2 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Biodexa Pharmaceuticals patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.